DMTC has released the digital version of its 2020 Annual Report.
This report features an overview of the Medical Countermeasures Program, including its successes over the past year and several project case studies from the program’s portfolio.
Posted by Emily Kibble on December 21st, 2020DMTC’s CEO Dr Mark Hodge and Dr Craig Rayner of Certara joined Matt Tribe on ABC’s Victoria Statewide Drive to discuss where Australia’s industrial capability is at in light of COVID-19
Posted by Emily Kibble on May 12th, 2020Dr Mitali Sarkar-Tyson from the School of Biomedical Sciences at The University of Western Australia received the coveted Collaboration Award at the 2020 DMTC Annual Conference.
Dr Sarkar-Tyson has shown an incredible work ethic and commitment to developing our sovereign industrial capability in the medical countermeasures domain over the last several years.
She is currently leading a DMTC project out of The University of Western Australia in collaboration with DST Group, the Peter Doherty Institute, the University of Wurzburg, the University of Exeter, DSTL and now Monash University. This project is developing novel anti-virulence compounds against a range of bio-warfare pathogens. In addition to the highly significant research she has conducted for this project, she has also contributed to 72 scientific research publications across the fields of antimicrobial resistance and molecular biology.
The DMTC Collaboration Award recognises an individual who embodies the spirit of collaboration, and Dr Sarkar-Tyson has truly embodied collaboration through bringing together a network of international researchers and coordinating a multi-disciplinary team that can respond to bio-threat pathogens and the growing threat of antimicrobial resistance.
Posted by Emily Kibble on April 14th, 2020 Tagged: AMR, collaboration, DMTC Annual Conference, Mitali Sarkar-Tyson, UWAProfessor Flavia Huygens received the Project Leadership Award at the 2020 DMTC Annual Conference.
Professor Huygens is Associate Director at the Institute of Health Biomedical Innovation (QIMR-Berghofer), a Professor at the School of Biomedical Sciences at Queensland University of Technology and a director of Australian med-tech start-up company, Microbio.
Professor Huygens has shown excellent project leadership over the last year in seamlessly bringing together a multidisciplinary team from academia and industry to develop a rapid diagnostic with her company Microbio, which is helping to address significant issues in the diagnosis of bio-threat pathogens.
She is the pioneer behind the technology of InfectID®, which uses novel and innovative bioinformatic tools to genetically identify blood/plasma borne bacteria. This technology has been shown to distinguish between more than 10 closely related pathogens without the generation of false positives. This type of technology is critical for the military to respond to outbreaks of infection or deliberate biological attacks.
The way Professor Huygens has managed the complexities of working across partners to meet the delivery requirements has been second to none.
Posted by Emily Kibble on April 14th, 2020 Tagged: DMTC Annual Conference, Flavia Huygens, InfectID, Microbio, QUT